{"Title": ["Why Lexicon Pharmaceuticals Stock Soared Today", "Lexicon Pharmaceuticals Inc (LXRX) Q1 2020 Earnings Call Transcript", "Lexicon Pharmaceuticals Inc (LXRX) Q4 2019 Earnings Call Transcript", "Validea's Top Five Healthcare Stocks Based On David Dreman - 1/19/2020", "Health Care Sector Update for 12/20/2019: ABEO, CBAY, LXRX, JNJ, PFE, ABT, MRK, AMGN", "Validea's Top Five Healthcare Stocks Based On David Dreman - 12/15/2019", "AGTC Awaits Data In Jan., EVFM Walks The Talk, Today's A Big Day For ALDX", "Why Roku, Ollie's Bargain Outlet Holdings, and Lexicon Pharmaceuticals Slumped Today", "Why Lexicon Pharmaceuticals Stock Soared Today", "Health Care Sector Update for 12/02/2019: ASLN, EVFM, LXRX, JNJ, PFE, ABT, MRK, AMGN", "Is Lexicon Pharmaceuticals a Buy?", "Lexicon Pharmaceuticals Inc (LXRX) Q3 2019 Earnings Call Transcript", "5 Top Gainers In Healthcare Sector (LXRX, ECOR, ARAV\u2026)", "7 Top Gainers In Healthcare Sector (KOD, LXRX, WVE...)", "Here\u2019s Why Lexicon Pharmaceuticals Rose 18% Today", "Week Ahead In Pharmaceuticals: 7 Stocks To Watch (AIMT, LXRX, TXG\u2026)", "Here's Why Lexicon Pharmaceuticals Is Tumbling Today", "Health Care Sector Update for 12/02/2019: ASLN, EVFM, LXRX, JNJ, PFE, ABT, MRK, AMGN", "Is Lexicon Pharmaceuticals a Buy?", "Lexicon Pharmaceuticals Inc (LXRX) Q3 2019 Earnings Call Transcript", "5 Top Gainers In Healthcare Sector (LXRX, ECOR, ARAV\u2026)", "7 Top Gainers In Healthcare Sector (KOD, LXRX, WVE...)", "Here\u2019s Why Lexicon Pharmaceuticals Rose 18% Today", "Week Ahead In Pharmaceuticals: 7 Stocks To Watch (AIMT, LXRX, TXG\u2026)", "Here's Why Lexicon Pharmaceuticals Is Tumbling Today", "Health Care Sector Update for 09/11/2019: ABIO,TTOO,LXRX,TLRY", "Health Care Sector Update for 09/11/2019: TTOO, LXRX, TLRY, SNY", "Health Care Sector Update for 09/11/2019: TTOO, LXRX, SNY, TLRY, JNJ, PFE, MRK, ABT, AMGN", "Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?", "6 Top Losers In Healthcare Sector (LXRX, XBIO, ONCY...)", "Why Cooper Tire & Rubber, Insperity, and Lexicon Pharmaceuticals Slumped Today", "Here's Why Lexicon Pharmaceuticals Is Collapsing Today", "Here's Why Lexicon Pharmaceuticals Is Soaring This Week", "Lexicon Pharmaceuticals Inc (LXRX) Q1 2019 Earnings Call Transcript", "Lexicon Falls as FDA Denies Approval to Type I Diabetes Drug", "AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes", "What's Next for Lexicon Pharmaceuticals?", "Why Zuora, Greenbrier, and Lexicon Pharmaceuticals Slumped Today", "Health Care Sector Update for 03/22/2019: LXRX,SNY,IRWD,IMMP,CNAT", "Lexicon Pharma Initiates Dosing in Biliary Tract Cancer Study", "Health Care Sector Update for 03/13/2019: NVCN, CASI, LXRX, JNJ, PFE, ABT, MRK, AMGN", "Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates", "Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2018 Earnings Conference Call Transcript", "Zacks.com featured highlights include: Lexicon, Medtronic and NetApp", "3 Stocks That Flaunt Solid Earnings Acceleration", "Friday's ETF Movers: XBI, RWR", "Here's Why Lexicon Pharmaceuticals Jumped as Much as 26.9% Today", "Mid-Afternoon Market Update: Crude Oil Down 2.5%; Nutanix Shares Plunge On Weak Forecast", "3 Top Diabetes Stocks to Watch in February", "Here's Why Lexicon Pharmaceuticals Lost 28.8% in January", "About to Buy Penny Stocks? Look at These 3 Companies First", "Wednesday's ETF Movers: ILF, XBI", "Here's Why Lexicon Pharmaceuticals Collapsed Today", "Health Care Sector Update for 01/18/2019: LXRX, SNY, SNSS, LLY, JNJ, PFE, MRK, ABT, AMGN", "Health Care Sector Update for 01/18/2019: CRON,LLY,EW,LXRX", "Will Lexicon Pharmaceuticals (LXRX) Report Negative Q4 Earnings? What You Should Know", "FDA Advisory Panel Splits Vote On Sanofi-Lexicon Diabetes Drug", "FDA advisory panel split over Sanofi-Lexicon diabetes drug", "Health Care Sector Update for 12/18/2018: LXRX, LLY, APHB, JNJ, PFE, ABT, MRK, APHB", "3 Top Biotech Stocks to Buy in December", "Biotech Stock Roundup: FDA Gives Nod to Amgen's Drugs, EU Approves Exelixis' Cabometyx", "3 Top Biotech Stocks to Buy Right Now", "Here's Why Lexicon Pharmaceuticals Dropped as Much as 13.6% Today", "Commit To Purchase Lexicon Pharmaceuticals At $7, Earn 12% Annualized Using Options", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Friday's ETF Movers: XBI, XLU", "Thursday's ETF Movers: XBI, XLP", "How to Invest in Diabetes Stocks", "Monday 9/18 Insider Buying Report: CLF, LXRX", "Lexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $376,200 of Shares", "3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street", "Lexicon (LXRX) Looks Good: Stock Adds 7.6% in Session", "Lexicon Pharmaceuticals Becomes Oversold (LXRX)", "Notable Monday Option Activity: LXRX, PCRX, AEIS", "News Flash: The FDA Just Approved a Breakthrough Diabetes Device", "Will Insiders Be Tempted To Buy More LXRX At The New 52-Week Low?", "Monday 9/18 Insider Buying Report: CLF, LXRX", "Lexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $376,200 of Shares", "3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street", "Lexicon Pharmaceuticals is Now Oversold (LXRX)", "Health Care Sector Update for 09/13/2017: LXRX,LOXO,AGTC", "Analysts Forecast 12% Upside For The Holdings of JKK", "5 of the Most Hated Biotech Stocks on the Market: Are They Buys?", "Notable Monday Option Activity: LXRX, NFLX, PRLB", "Oversold Conditions For Lexicon Pharmaceuticals (LXRX)", "3 Stocks That Could Be Life-Changers", "Why Lexicon Pharmaceuticals Is Down 11% Today", "Wednesday's ETF with Unusual Volume: XT", "Mid-Morning Market Update: Markets Edge Lower; Big Lots Profit Beats Estimates", "Earnings Reaction History: Lexicon Pharmaceuticals Inc., 33.3% Follow-Through Indicator, 4.6% Sensitive", "Noteworthy Thursday Option Activity: LGND, LXRX, REGN", "Interesting LXRX Put And Call Options For October 20th", "3 Stocks We're Watching in the First Quarter", "Bullish Two Hundred Day Moving Average Cross - LXRX", "Lexicon Pharmaceuticals (LXRX) Shares Cross Below 200 DMA", "Wednesday's ETF with Unusual Volume: XT", "Mid-Morning Market Update: Markets Edge Lower; Big Lots Profit Beats Estimates", "Earnings Reaction History: Lexicon Pharmaceuticals Inc., 33.3% Follow-Through Indicator, 4.6% Sensitive", "Noteworthy Thursday Option Activity: LGND, LXRX, REGN", "Interesting LXRX Put And Call Options For October 20th", "3 Stocks We're Watching in the First Quarter", "Bullish Two Hundred Day Moving Average Cross - LXRX", "Lexicon Pharmaceuticals (LXRX) Shares Cross Below 200 DMA", "4 FDA Decisions to Watch Out for in Feb 2017", "5 Small-Cap Biotech Stocks to Buy in February", "5 Biotech Stocks You'll Want to Watch in the 1st Quarter", "3 Big Stock Charts: Intel Corporation (INTC), Western Digital Corp (WDC) and Lexicon Pharmaceuticals, Inc. (LXRX)", "This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspective", "Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News", "Is This Lexicon Pharmaceuticals' Year?", "Noteworthy Tuesday Option Activity: LULU, MANH, LXRX", "PTH's Holdings Could Mean 11% Gain Potential", "3 Biotechs With Potential Big-Time Upside", "Mid-Morning Market Update: Markets Open Lower; Kroger Lowers FY Forecast", "Correction: Stock Futures Spooked by Boston Fed President Rosengren, North Korean Missile Test", "Stock Futures Spooked by Boston Fed President Rosengren, North Korean Missile Test", "Pre-Market Most Active for Sep 9, 2016 : AZN, QQQ, LXRX, BAC, VOD, CRH, TVIX, XIV, CHK, RH, TWTR, PDCE", "Lexicon Hits 52-Week High on Positive Type I Diabetes Data", "Company News for September 12, 2016", "Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 16.6%", "Midday Update: Stocks Blind-Sided By Rosengren's Hawkish Rhetoric", "Mid-Morning Market Update: Markets Open Lower; Kroger Lowers FY Forecast", "Correction: Stock Futures Spooked by Boston Fed President Rosengren, North Korean Missile Test", "Stock Futures Spooked by Boston Fed President Rosengren, North Korean Missile Test", "Analysts Forecast 10% Gains Ahead For JKK", "Why Finisar, Lexicon Pharmaceuticals, and Zumiez Jumped Today", "Why El Pollo LoCo Holdings Inc (LOCO), Lexicon Pharmaceuticals, Inc. (LXRX) And Restoration Hardware Holdings Inc (RH) Are 3 of Today\u2019s Best Stocks", "Close Update: U.S. Stocks Plunge on Fed Rate Fears as Dow, S&P 500 Hit Two-Month Lows", "Why Lexicon Pharmaceuticals Skyrocketed 17% Today", "Health Care Sector Update for 09/09/2016: APVO,LXRX,LNTH", "Implied DWAQ Analyst Target Price: $80", "Pre-Market Earnings Report for March 1, 2016 : MDT, BNS, JD, AZO, DLTR, DCI, KATE, LXRX, JKS, STKL, WMC, NEO", "Commit To Buy Lexicon Pharmaceuticals At $7.50, Earn 22.6% Annualized Using Options", "After Hours Most Active for Jun 23, 2016 : FBHS, BAC, TVIX, AA, FCX, MSFT, DOW, HPE, XIV, WFM, LXRX, AAPL", "3 Biotech Stocks to Buy in June", "LXRX January 2017 Options Begin Trading", "LXRX Crosses Below Key Moving Average Level", "Commit To Buy Lexicon Pharmaceuticals At $12.50, Earn 33.8% Annualized Using Options", "Implied DWAQ Analyst Target Price: $80", "Pre-Market Earnings Report for March 1, 2016 : MDT, BNS, JD, AZO, DLTR, DCI, KATE, LXRX, JKS, STKL, WMC, NEO", "Commit To Buy Lexicon Pharmaceuticals At $7.50, Earn 22.6% Annualized Using Options", "After Hours Most Active for Jun 23, 2016 : FBHS, BAC, TVIX, AA, FCX, MSFT, DOW, HPE, XIV, WFM, LXRX, AAPL", "Oversold Conditions For Lexicon Pharmaceuticals (LXRX)", "15 Best Stocks to Ring Out the Old, Ring In the New", "Top Biotech Stocks to Buy in 2016", "Lexicon Reveals Positive Data on Carcinoid Syndrome Drug", "First Week of July 2016 Options Trading For Lexicon Pharmaceuticals (LXRX)", "Lexicon Pharmaceuticals (LXRX) Shares March Higher, Can It Continue?", "Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 23.7%", "These Secret Ingredients Led Lexicon Pharmaceuticals, Inc. Up 109% in 2015", "Health Care Sector Update for 11/06/2015: IDRA, LXRX, SNY", "Lexicon Pharmaceuticals Explodes Higher -- Here's What's Fueling the Surge", "After Hours Most Active for Oct 26, 2015 : GE, FITB, STE, AMCN, EMC, LXRX, STX, RP, DSKY, CAF, XOM, STT", "Health Care Sector Update for 10/09/2015: JAZZ, LXRX, IPCI", "Lexicon Presents Positive Data from Telotristat Etiprate Study", "Hillary Clinton's $40 Billion Tweet Breaks Biotech Stocks -- Which 3 Got Hit Hardest?", "Here's Why Lexicon Pharmaceuticals' Stock Exploded Higher in August", "Mid-Morning Market Update: Markets Decline; Humana Earnings Beat Estimates", "Mid-Morning Market Update: Markets Edge Higher; Coach Beats Q4 Expectations", "Lexicon Pharmaceuticals (LXRX) in Focus: Stock Rises 61.1% - Tale of the Tape", "Pre-Market Most Active for Aug 3, 2015 : FTR, LXRX, NOK, GLBL, FIT, TSN, AAPL, GSK, BAC, WBK, QQQ, MU", "Mid-Afternoon Market Update: Dow Dips Over 100 Points; Crude Oil Tumbles 5.5%", "Lexicon Pharmaceuticals (LXRX) Shares March Higher, Can It Continue? - Tale of the Tape", "Health Care Sector Update for 04/15/2015: LXRX, GLMD, NAVB", "Health Care Sector Update for 04/15/2015: LXRX,BMY,CLSN,AKBA", "3 Biotech Stocks Bucking the Stock Market Crash", "Lexicon-Ipsen Agreement Expanded to Include Canada - Analyst Blog", "Health Care Sector Update for 03/09/2015: LXRX, HTBX, CTIC", "AeroVironment Surges On Upbeat Results; The Container Store Shares Slide", "Markets Edge Higher; Alcoa Profit Beats Street View", "FOMC To End QE In October; The Container Store Shares Slide", "Encouraging Results from Lexicon Candidate - Analyst Blog", "Health Care Sector Update for 11/20/2014: LXRX,CYBX,RMTI", "Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape", "7 States Where Diabetes Prevalence Is the Highest", "Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape", "AeroVironment Surges On Upbeat Results; The Container Store Shares Slide", "Markets Edge Higher; Alcoa Profit Beats Street View", "FOMC To End QE In October; The Container Store Shares Slide", "Encouraging Results from Lexicon Candidate - Analyst Blog", "Health Care Sector Update for 11/20/2014: LXRX,CYBX,RMTI", "Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatment", "Sector Update: Healthcares", "Setback for Lexicon Pharma - Analyst Blog", "Biotech Stock Roundup: CBST Hits 52-Week High, OREX Lights Up - Analyst Blog", "Sector Update: Healthcare Shares Flat to Lower; Lexicon Drops 13% on Phase 2 Study of IBS Treatment", "Sector Update: Healthcare", "Sector Update: Healthcare", "Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat Estimates", "Pre-Market Most Active for Oct 1, 2013 : EDG, FB, ACTV, UN, ALU, LXRX, BAC, MRK, QQQ, ERIC, SIRI, MDLZ", "Sector Update: Healthcare Shares Higher Pre-Market; Lexicon Surges 21% on Glucose Inhibitor's Success", "Sector Update: Healthcare", "Healthcare Shares Rise; Lexicon Pharma Climbs Over 20% on Positive Results for Prospective Diabetes Drug", "Market Wrap for Monday, April 29: Stocks Start Week With a Rally"], "Elapsed Time": ["APR 27, 2020", "APR 27, 2020", "MAR 12, 2020", "JAN 19, 2020", "DEC 20, 2019", "DEC 15, 2019", "DEC 3, 2019", "DEC 2, 2019", "APR 27, 2020", "DEC 2, 2019", "NOV 27, 2019", "NOV 7, 2019", "SEP 18, 2019", "SEP 16, 2019", "SEP 16, 2019", "SEP 14, 2019", "DEC 2, 2019", "DEC 2, 2019", "NOV 27, 2019", "NOV 7, 2019", "SEP 18, 2019", "SEP 16, 2019", "SEP 16, 2019", "SEP 14, 2019", "DEC 2, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 5, 2019", "JUL 29, 2019", "JUL 29, 2019", "JUL 29, 2019", "SEP 12, 2019", "MAY 1, 2019", "MAR 25, 2019", "MAR 25, 2019", "MAR 25, 2019", "MAR 22, 2019", "MAR 22, 2019", "MAR 18, 2019", "MAR 13, 2019", "MAR 13, 2019", "MAR 13, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 1, 2019", "FEB 17, 2019", "FEB 11, 2019", "JAN 29, 2019", "JAN 23, 2019", "JAN 18, 2019", "JAN 18, 2019", "JAN 18, 2019", "FEB 21, 2019", "JAN 17, 2019", "JAN 17, 2019", "DEC 18, 2018", "DEC 11, 2018", "MAY 23, 2018", "APR 21, 2018", "FEB 14, 2018", "AUG 22, 2018", "JUN 2, 2018", "JUN 1, 2018", "MAY 31, 2018", "MAY 25, 2018", "SEP 18, 2017", "SEP 18, 2017", "JAN 21, 2018", "NOV 16, 2017", "OCT 20, 2017", "OCT 16, 2017", "OCT 8, 2017", "OCT 3, 2017", "SEP 18, 2017", "SEP 18, 2017", "JAN 21, 2018", "SEP 13, 2017", "SEP 13, 2017", "SEP 12, 2017", "SEP 1, 2017", "AUG 21, 2017", "AUG 8, 2017", "JUL 25, 2017", "SEP 14, 2017", "MAR 8, 2017", "MAR 3, 2017", "MAR 3, 2017", "MAR 2, 2017", "FEB 22, 2017", "FEB 14, 2017", "FEB 10, 2017", "MAR 13, 2017", "MAR 8, 2017", "MAR 3, 2017", "MAR 3, 2017", "MAR 2, 2017", "FEB 22, 2017", "FEB 14, 2017", "FEB 10, 2017", "MAR 13, 2017", "JAN 31, 2017", "JAN 25, 2017", "SEP 22, 2016", "SEP 19, 2016", "SEP 19, 2016", "SEP 14, 2016", "SEP 13, 2016", "OCT 18, 2016", "SEP 30, 2016", "SEP 26, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "JUL 13, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "APR 14, 2016", "MAR 26, 2016", "FEB 29, 2016", "JAN 14, 2016", "JUN 23, 2016", "MAY 27, 2016", "MAY 23, 2016", "MAY 12, 2016", "APR 14, 2016", "MAR 26, 2016", "FEB 29, 2016", "JAN 14, 2016", "JUN 23, 2016", "JAN 8, 2016", "DEC 31, 2015", "DEC 21, 2015", "DEC 2, 2015", "NOV 24, 2015", "NOV 13, 2015", "NOV 9, 2015", "JAN 8, 2016", "NOV 6, 2015", "NOV 6, 2015", "OCT 26, 2015", "OCT 9, 2015", "SEP 30, 2015", "SEP 22, 2015", "SEP 10, 2015", "NOV 6, 2015", "AUG 4, 2015", "AUG 4, 2015", "AUG 3, 2015", "JUL 6, 2015", "JUN 10, 2015", "APR 15, 2015", "APR 15, 2015", "AUG 28, 2015", "MAR 19, 2015", "MAR 9, 2015", "JUL 9, 2014", "JUL 9, 2014", "JUL 9, 2014", "APR 15, 2014", "NOV 20, 2014", "OCT 17, 2014", "SEP 6, 2014", "JUL 10, 2014", "JUL 9, 2014", "JUL 9, 2014", "JUL 9, 2014", "APR 15, 2014", "NOV 20, 2014", "APR 14, 2014", "APR 14, 2014", "DEC 5, 2013", "DEC 4, 2013", "DEC 3, 2013", "DEC 3, 2013", "OCT 9, 2013", "APR 14, 2014", "OCT 1, 2013", "OCT 1, 2013", "OCT 1, 2013", "OCT 1, 2013", "APR 29, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/why-lexicon-pharmaceuticals-stock-soared-today-2020-04-27", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-q1-2020-earnings-call-transcript-2020-04-27", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-q4-2019-earnings-call-transcript-2020-03-12", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-20-2019%3A-abeo-cbay-lxrx-jnj-pfe-abt-mrk-amgn-2019-12-20", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/agtc-awaits-data-in-jan.-evfm-walks-the-talk-todays-a-big-day-for-aldx-2019-12-03", "https://www.nasdaq.com/articles/why-roku-ollies-bargain-outlet-holdings-and-lexicon-pharmaceuticals-slumped-today-2019-12", "https://www.nasdaq.com/articles/why-lexicon-pharmaceuticals-stock-soared-today-2020-04-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-02-2019%3A-asln-evfm-lxrx-jnj-pfe-abt-mrk-amgn-2019-12-02", "https://www.nasdaq.com/articles/is-lexicon-pharmaceuticals-a-buy-2019-11-27", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-q3-2019-earnings-call-transcript-2019-11-07", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-lxrx-ecor-arav...-2019-09-18", "https://www.nasdaq.com/articles/7-top-gainers-in-healthcare-sector-kod-lxrx-wve...-2019-09-16", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-rose-18-today-2019-09-16", "https://www.nasdaq.com/articles/week-ahead-in-pharmaceuticals%3A-7-stocks-to-watch-aimt-lxrx-txg...-2019-09-14", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-is-tumbling-today-2019-12-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-02-2019%3A-asln-evfm-lxrx-jnj-pfe-abt-mrk-amgn-2019-12-02", "https://www.nasdaq.com/articles/is-lexicon-pharmaceuticals-a-buy-2019-11-27", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-q3-2019-earnings-call-transcript-2019-11-07", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-lxrx-ecor-arav...-2019-09-18", "https://www.nasdaq.com/articles/7-top-gainers-in-healthcare-sector-kod-lxrx-wve...-2019-09-16", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-rose-18-today-2019-09-16", "https://www.nasdaq.com/articles/week-ahead-in-pharmaceuticals%3A-7-stocks-to-watch-aimt-lxrx-txg...-2019-09-14", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-is-tumbling-today-2019-12-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-11-2019%3A-abiottoolxrxtlry-2019-09-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-11-2019%3A-ttoo-lxrx-tlry-sny-2019-09-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-11-2019%3A-ttoo-lxrx-sny-tlry-jnj-pfe-mrk-abt-amgn-2019-09", "https://www.nasdaq.com/articles/is-the-fda-out-to-get-this-%242.9-billion-diabetes-drug-class-2019-09-05", "https://www.nasdaq.com/articles/6-top-losers-in-healthcare-sector-lxrx-xbio-oncy...-2019-07-29", "https://www.nasdaq.com/articles/why-cooper-tire-rubber-insperity-and-lexicon-pharmaceuticals-slumped-today-2019-07-29", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-is-collapsing-today-2019-07-29", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-is-soaring-this-week-2019-09-12", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-q1-2019-earnings-call-transcript-2019-05-01", "https://www.nasdaq.com/articles/lexicon-falls-as-fda-denies-approval-to-type-i-diabetes-drug-2019-03-25", "https://www.nasdaq.com/articles/astrazenecas-forxiga-gets-ec-approval-for-type-i-diabetes-2019-03-25", "https://www.nasdaq.com/articles/whats-next-lexicon-pharmaceuticals-2019-03-25", "https://www.nasdaq.com/articles/why-zuora-greenbrier-and-lexicon-pharmaceuticals-slumped-today-2019-03-22", "https://www.nasdaq.com/articles/health-care-sector-update-03222019-lxrxsnyirwdimmpcnat-2019-03-22", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-25-nutanix-shares-plunge-weak-forecast-2019-03", "https://www.nasdaq.com/articles/health-care-sector-update-03132019-nvcn-casi-lxrx-jnj-pfe-abt-mrk-amgn-2019-03-13", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-reports-q4-loss-tops-revenue-estimates-2019-03-13", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-q4-2018-earnings-conference-call-transcript-2019-03-13", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-lexicon-medtronic-and-netapp-2019-03-08", "https://www.nasdaq.com/articles/3-stocks-flaunt-solid-earnings-acceleration-2019-03-07", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-rwr-2019-03-01", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-jumped-much-269-today-2019-03-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-25-nutanix-shares-plunge-weak-forecast-2019-03", "https://www.nasdaq.com/articles/3-top-diabetes-stocks-watch-february-2019-02-17", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-lost-288-january-2019-02-11", "https://www.nasdaq.com/articles/about-buy-penny-stocks-look-these-3-companies-first-2019-01-29", "https://www.nasdaq.com/articles/wednesdays-etf-movers-ilf-xbi-2019-01-23", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-collapsed-today-2019-01-18", "https://www.nasdaq.com/articles/health-care-sector-update-01182019-lxrx-sny-snss-lly-jnj-pfe-mrk-abt-amgn-2019-01-18", "https://www.nasdaq.com/articles/health-care-sector-update-01182019-cronllyewlxrx-2019-01-18", "https://www.nasdaq.com/articles/will-lexicon-pharmaceuticals-lxrx-report-negative-q4-earnings-what-you-should-know-2019-02", "https://www.nasdaq.com/articles/fda-advisory-panel-splits-vote-sanofi-lexicon-diabetes-drug-2019-01-17", "https://www.nasdaq.com/articles/fda-advisory-panel-split-over-sanofi-lexicon-diabetes-drug-2019-01-17", "https://www.nasdaq.com/articles/health-care-sector-update-12182018-lxrx-lly-aphb-jnj-pfe-abt-mrk-aphb-2018-12-18", "https://www.nasdaq.com/articles/how-invest-diabetes-stocks-2018-05-25", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-fda-gives-nod-to-amgens-drugs-eu-approves-exelixis-cabometyx-2018", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-04-21", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-dropped-much-136-today-2018-02-14", "https://www.nasdaq.com/articles/commit-purchase-lexicon-pharmaceuticals-7-earn-12-annualized-using-options-2018-08-22", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-06-02", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-xlu-2018-06-01", "https://www.nasdaq.com/articles/thursdays-etf-movers-xbi-xlp-2018-05-31", "https://www.nasdaq.com/articles/how-invest-diabetes-stocks-2018-05-25", "https://www.nasdaq.com/articles/monday-918-insider-buying-report-clf-lxrx-2017-09-18", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-president-and-ceo-lonnel-coats-bought-376200-shares-2017", "https://www.nasdaq.com/articles/3-fastest-growing-diabetes-stocks-2018-according-wall-street-2018-01-21", "https://www.nasdaq.com/articles/lexicon-lxrx-looks-good%3A-stock-adds-7.6-in-session-2017-11-16", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-becomes-oversold-lxrx-2017-10-20", "https://www.nasdaq.com/articles/notable-monday-option-activity-lxrx-pcrx-aeis-2017-10-16", "https://www.nasdaq.com/articles/news-flash-fda-just-approved-breakthrough-diabetes-device-2017-10-08", "https://www.nasdaq.com/articles/will-insiders-be-tempted-buy-more-lxrx-new-52-week-low-2017-10-03", "https://www.nasdaq.com/articles/monday-918-insider-buying-report-clf-lxrx-2017-09-18", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-inc-lxrx-president-and-ceo-lonnel-coats-bought-376200-shares-2017", "https://www.nasdaq.com/articles/3-fastest-growing-diabetes-stocks-2018-according-wall-street-2018-01-21", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-now-oversold-lxrx-2017-09-13", "https://www.nasdaq.com/articles/health-care-sector-update-09132017-lxrxloxoagtc-2017-09-13", "https://www.nasdaq.com/articles/analysts-forecast-12-upside-holdings-jkk-2017-09-12", "https://www.nasdaq.com/articles/5-most-hated-biotech-stocks-market-are-they-buys-2017-09-01", "https://www.nasdaq.com/articles/notable-monday-option-activity-lxrx-nflx-prlb-2017-08-21", "https://www.nasdaq.com/articles/oversold-conditions-lexicon-pharmaceuticals-lxrx-2017-08-08", "https://www.nasdaq.com/articles/3-stocks-could-be-life-changers-2017-07-25", "https://www.nasdaq.com/articles/why-lexicon-pharmaceuticals-down-11-today-2017-09-14", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-xt-2017-03-08", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-big-lots-profit-beats-estimates-2017-03-03", "https://www.nasdaq.com/articles/earnings-reaction-history-lexicon-pharmaceuticals-inc-333-follow-through-indicator-46", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-lgnd-lxrx-regn-2017-03-02", "https://www.nasdaq.com/articles/interesting-lxrx-put-and-call-options-october-20th-2017-02-22", "https://www.nasdaq.com/articles/3-stocks-were-watching-first-quarter-2017-02-14", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-lxrx-2017-02-10", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-shares-cross-below-200-dma-2017-03-13", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-xt-2017-03-08", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-big-lots-profit-beats-estimates-2017-03-03", "https://www.nasdaq.com/articles/earnings-reaction-history-lexicon-pharmaceuticals-inc-333-follow-through-indicator-46", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-lgnd-lxrx-regn-2017-03-02", "https://www.nasdaq.com/articles/interesting-lxrx-put-and-call-options-october-20th-2017-02-22", "https://www.nasdaq.com/articles/3-stocks-were-watching-first-quarter-2017-02-14", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-lxrx-2017-02-10", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-shares-cross-below-200-dma-2017-03-13", "https://www.nasdaq.com/articles/4-fda-decisions-watch-out-feb-2017-2017-01-31", "https://www.nasdaq.com/articles/5-small-cap-biotech-stocks-buy-february-2017-01-25", "https://www.nasdaq.com/articles/10-stocks-that-should-be-in-your-portfolio-right-now-2016-09-22", "https://www.nasdaq.com/articles/3-big-stock-charts%3A-intel-corporation-intc-western-digital-corp-wdc-and-lexicon", "https://www.nasdaq.com/articles/diabetes-breakthrough-great-news-or-terrible-news-depending-your-perspective-2016-09-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-horizon-raptor-acquisition-deal-geron-down-pipeline-news-2016-09-14", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-year-2016-09-13", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-lulu-manh-lxrx-2016-10-18", "https://www.nasdaq.com/articles/pths-holdings-could-mean-11-gain-potential-2016-09-30", "https://www.nasdaq.com/articles/3-biotechs-potential-big-time-upside-2016-09-26", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-kroger-lowers-fy-forecast-2016-09-09", "https://www.nasdaq.com/articles/correction-stock-futures-spooked-boston-fed-president-rosengren-north-korean-missile-test", "https://www.nasdaq.com/articles/stock-futures-spooked-boston-fed-president-rosengren-north-korean-missile-test-2016-09-09", "https://www.nasdaq.com/articles/pre-market-most-active-sep-9-2016-azn-qqq-lxrx-bac-vod-crh-tvix-xiv-chk-rh-twtr-pdce-2016", "https://www.nasdaq.com/articles/lexicon-hits-52-week-high-on-positive-type-i-diabetes-data-2016-09-12", "https://www.nasdaq.com/articles/company-news-for-september-12-2016-2016-09-12", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-jumps%3A-stock-rises-16.6-2016-09-12", "https://www.nasdaq.com/articles/midday-update-stocks-blind-sided-rosengrens-hawkish-rhetoric-2016-09-09", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-kroger-lowers-fy-forecast-2016-09-09", "https://www.nasdaq.com/articles/correction-stock-futures-spooked-boston-fed-president-rosengren-north-korean-missile-test", "https://www.nasdaq.com/articles/7-biotech-stocks-to-watch-for-runaway-gains-2016-07-21", "https://www.nasdaq.com/articles/analysts-forecast-10-gains-ahead-jkk-2016-07-13", "https://www.nasdaq.com/articles/why-finisar-lexicon-pharmaceuticals-and-zumiez-jumped-today-2016-09-09", "https://www.nasdaq.com/articles/why-el-pollo-loco-holdings-inc-loco-lexicon-pharmaceuticals-inc.-lxrx-and-restoration", "https://www.nasdaq.com/articles/close-update-us-stocks-plunge-fed-rate-fears-dow-sp-500-hit-two-month-lows-2016-09-09", "https://www.nasdaq.com/articles/why-lexicon-pharmaceuticals-skyrocketed-17-today-2016-09-09", "https://www.nasdaq.com/articles/commit-buy-lexicon-pharmaceuticals-1250-earn-338-annualized-using-options-2016-04-14", "https://www.nasdaq.com/articles/implied-dwaq-analyst-target-price-80-2016-03-26", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-1-2016-mdt-bns-jd-azo-dltr-dci-kate-lxrx-jks-stkl-wmc-neo", "https://www.nasdaq.com/articles/commit-buy-lexicon-pharmaceuticals-750-earn-226-annualized-using-options-2016-01-14", "https://www.nasdaq.com/articles/after-hours-most-active-jun-23-2016-fbhs-bac-tvix-aa-fcx-msft-dow-hpe-xiv-wfm-lxrx-aapl", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-june-2016-05-27", "https://www.nasdaq.com/articles/lxrx-january-2017-options-begin-trading-2016-05-23", "https://www.nasdaq.com/articles/lxrx-crosses-below-key-moving-average-level-2016-05-12", "https://www.nasdaq.com/articles/commit-buy-lexicon-pharmaceuticals-1250-earn-338-annualized-using-options-2016-04-14", "https://www.nasdaq.com/articles/implied-dwaq-analyst-target-price-80-2016-03-26", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-1-2016-mdt-bns-jd-azo-dltr-dci-kate-lxrx-jks-stkl-wmc-neo", "https://www.nasdaq.com/articles/commit-buy-lexicon-pharmaceuticals-750-earn-226-annualized-using-options-2016-01-14", "https://www.nasdaq.com/articles/after-hours-most-active-jun-23-2016-fbhs-bac-tvix-aa-fcx-msft-dow-hpe-xiv-wfm-lxrx-aapl", "https://www.nasdaq.com/articles/oversold-conditions-lexicon-pharmaceuticals-lxrx-2016-01-08", "https://www.nasdaq.com/articles/15-best-stocks-ring-out-old-ring-new-2015-12-31", "https://www.nasdaq.com/articles/top-biotech-stocks-buy-2016-2015-12-21", "https://www.nasdaq.com/articles/lexicon-reveals-positive-data-on-carcinoid-syndrome-drug-2015-12-02", "https://www.nasdaq.com/articles/first-week-july-2016-options-trading-lexicon-pharmaceuticals-lxrx-2015-11-24", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-shares-march-higher-can-it-continue-2015-11-13", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-jumps%3A-stock-rises-23.7-2015-11-09", "https://www.nasdaq.com/articles/these-secret-ingredients-led-lexicon-pharmaceuticals-inc-109-2015-2016-01-08", "https://www.nasdaq.com/articles/health-care-sector-update-11062015-idra-lxrx-sny-2015-11-06", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-explodes-higher-heres-whats-fueling-surge-2015-11-06", "https://www.nasdaq.com/articles/after-hours-most-active-oct-26-2015-ge-fitb-ste-amcn-emc-lxrx-stx-rp-dsky-caf-xom-stt-2015", "https://www.nasdaq.com/articles/health-care-sector-update-10092015-jazz-lxrx-ipci-2015-10-09", "https://www.nasdaq.com/articles/lexicon-presents-positive-data-from-telotristat-etiprate-study-2015-09-30", "https://www.nasdaq.com/articles/hillary-clintons-40-billion-tweet-breaks-biotech-stocks-which-3-got-hit-hardest-2015-09-22", "https://www.nasdaq.com/articles/heres-why-lexicon-pharmaceuticals-stock-exploded-higher-august-2015-09-10", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-decline-humana-earnings-beat-estimates-2015-11-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-coach-beats-q4-expectations-2015-08-04", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-in-focus%3A-stock-rises-61.1-tale-of-the-tape-2015-08-04", "https://www.nasdaq.com/articles/pre-market-most-active-aug-3-2015-ftr-lxrx-nok-glbl-fit-tsn-aapl-gsk-bac-wbk-qqq-mu-2015", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-dips-over-100-points-crude-oil-tumbles-55-2015-07-06", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-shares-march-higher-can-it-continue-tale-of-the-tape-2015-06", "https://www.nasdaq.com/articles/health-care-sector-update-04152015-lxrx-glmd-navb-2015-04-15", "https://www.nasdaq.com/articles/health-care-sector-update-04152015-lxrxbmyclsnakba-2015-04-15", "https://www.nasdaq.com/articles/3-biotech-stocks-bucking-stock-market-crash-2015-08-28", "https://www.nasdaq.com/articles/lexicon-ipsen-agreement-expanded-to-include-canada-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/health-care-sector-update-03092015-lxrx-htbx-ctic-2015-03-09", "https://www.nasdaq.com/articles/aerovironment-surges-upbeat-results-container-store-shares-slide-2014-07-09", "https://www.nasdaq.com/articles/markets-edge-higher-alcoa-profit-beats-street-view-2014-07-09", "https://www.nasdaq.com/articles/fomc-end-qe-october-container-store-shares-slide-2014-07-09", "https://www.nasdaq.com/articles/encouraging-results-from-lexicon-candidate-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/health-care-sector-update-11202014-lxrxcybxrmti-2014-11-20", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-jumps%3A-stock-rises-15.7-tale-of-the-tape-2014-10-17", "https://www.nasdaq.com/articles/7-states-where-diabetes-prevalence-highest-2014-09-06", "https://www.nasdaq.com/articles/lexicon-lxrx-jumps%3A-stock-moves-7.6-higher-tale-of-the-tape-2014-07-10", "https://www.nasdaq.com/articles/aerovironment-surges-upbeat-results-container-store-shares-slide-2014-07-09", "https://www.nasdaq.com/articles/markets-edge-higher-alcoa-profit-beats-street-view-2014-07-09", "https://www.nasdaq.com/articles/fomc-end-qe-october-container-store-shares-slide-2014-07-09", "https://www.nasdaq.com/articles/encouraging-results-from-lexicon-candidate-analyst-blog-2014-04-15", "https://www.nasdaq.com/articles/health-care-sector-update-11202014-lxrxcybxrmti-2014-11-20", "https://www.nasdaq.com/articles/sector-update-healthcares-flat-lower-pre-market-lexicon-soars-20-study-diabetes-treatment", "https://www.nasdaq.com/articles/sector-update-healthcares-2014-04-14", "https://www.nasdaq.com/articles/setback-for-lexicon-pharma-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-cbst-hits-52-week-high-orex-lights-analyst-blog-2013-12-04", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-lower-lexicon-drops-13-phase-2-study-ibs-treatment", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-03", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-09", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-citigroup-results-beat-estimates-2014-04-14", "https://www.nasdaq.com/articles/pre-market-most-active-oct-1-2013-edg-fb-actv-un-alu-lxrx-bac-mrk-qqq-eric-siri-mdlz-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-higher-pre-market-lexicon-surges-21-glucose-inhibitors", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-01", "https://www.nasdaq.com/articles/healthcare-shares-rise-lexicon-pharma-climbs-over-20-positive-results-prospective-diabetes", "https://www.nasdaq.com/articles/market-wrap-monday-april-29-stocks-start-week-rally-2013-04-29"], "Content": []}